KalVista Shares Surge as FDA Approves New Drug After Delay
KalVista Pharmaceuticals Inc. shares rose 19% early Monday after the company said it received US Food and Drug Administration approval…
13,500€
2,27%
Echtzeit-Aktienkurs KalVista Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur KalVista Pharmaceuticals Inc. Aktie
US FDA approves KalVista Pharmas swelling disorder drug
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary…